Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Supernus Pharmaceuticals Inc (SUPN)
Supernus Pharmaceuticals Inc (SUPN) Financials

SUPN Supernus Pharmaceuticals Inc

36.57

-0.42 (-1.14%)

29 Nov 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	36.613	15.608	15.83	10.575	9.529	3.346	3.58	0.088
Return on Equity (%)	58.733	24.948	30.81	21.566	18.944	6.846	7.134	0.146
Return on Invested Capital (%)	148.552	73.761	53.99	36.72	34.202	16.128	10.109	8.464
Operating Margin (%)	25.795	33.81	38.711	43.333	36.972	16.661	10.163	0.853
Net Profit Margin (%)	42.428	18.953	27.144	28.785	24.395	9.215	9.099	0.217
Book Value Per Share	3.507	4.511	8.06	10.862	5.724	-1.622	1.23	3.745
Earnings Per Share	1.825	1.116	2.122	2.152	2.401	1.003	1.119	0.024
Cash Per Share	1.329	1.955	3.675	3.453	5.46	3.82	1.716	1.374
Working Capital Per Share	1.414	2.055	6.348	5.94	7.288	5.374	0.851	3.714
Operating Profit Per Share	4.111	5.751	7.658	7.286	8.932	9.649	10.754	9.66
EBIT Per Share	1.008	1.961	2.679	2.808	3.19	1.374	1.12	0.051
EBITDA Per Share	1.008	1.961	2.679	2.808	3.19	1.374	1.12	0.051
Free Cash Flow Per Share	2.186	1.215	2.017	2.077	2.088	0.43	-0.45	-1.519

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	49.97M	51.32M	52.32M	52.53M	52.87M	53.26M	54.25M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	54.25M	N/A	N/A	N/A	N/A	54.97M	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	6.843	N/A	N/A	N/A	0.169	N/A	N/A
Net Profit Margin (%)	N/A	11.022	N/A	N/A	N/A	0.086	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	2.04B
Price to Earnings Ratio	1.54k
Price to Sales Ratio	3.32
Price to Cash Ratio	26.91
Price to Book Ratio	2.19
Dividend Yield	-

Share Statistics

Shares Outstanding	55.22M
Average Volume (1 week)	297.23k
Average Volume (1 Month)	427.74k
52 Week Change	34.94%
52 Week High	39.37
52 Week Low	25.53

More Ratios Coming Soon!

Supernus Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions